
In a powerful step toward revolutionizing women’s health, eSense Health Inc. has announced the results of a pivotal clinical trial proving the effectiveness of its digital therapy platform, eSense, in treating Female Sexual Interest/Arousal Disorder (SIAD)—a condition that impacts up to 40% of women. Published in the respected peer-reviewed journal Behaviour Research & Therapy, this trial marks a significant milestone in how sexual wellness can be treated—privately, affordably, and effectively—especially for those...